Evaluation of thiopyrano[2,3‐ d ]thiazole derivatives as potential anticonvulsant agents
Archiv der Pharmazie · 2024
DOI: 10.1002/ardp.202400357 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2024. Verfasst von Eduard Davydov und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Pharmacotherapy, National Pharmaceutical University, Kharkiv, Ukraine. Hauptthemen laut MEDLINE: Anticonvulsants, Thiazoles, Seizures, Molecular Docking Simulation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Verkhovna Rada of Ukraine.
Abstract (Originalsprache)
Anticonvulsant drug discovery has achieved significant progress; however, pharmacotherapy of epilepsy continues to be a challenge for modern medicine and pharmacy. To expand the chemical space of heterocycles as potential antiepileptic agents, herein we report on the synthesis and evaluation of anticonvulsant properties of a series of thiopyrano[2,3‐ d ]thiazoles. The studied heterocycles are characterized by satisfactory drug‐likeness and pharmacokinetics properties, calculated in silico using SwissADME. The anticonvulsant activity of thiopyrano[2,3‐ d ]thiazole derivatives was evaluated in vivo using the subcutaneous pentylenetetrazole test. Three hits, that is, compounds 12 , 14 , and 16 , that caused a pronounced anticonvulsant effect were identified. Derivatives 12 , 14 , and 16 positively affected the latent period of onset of clonic seizures, number of seizures, mortality rate, and duration of the seizure period of animals under experimental conditions. The anticonvulsant properties of compound 14 were equivalent to the effect of the reference drug, sodium valproate. All hit compounds are characterized by satisfying toxicity properties in the human lymphocytes and HEK293 cell line. The most active hit 14 possesses a potential affinity with the GABA A receptor in the molecular docking study and forms a stable complex in the molecular dynamics experiments equal to diazepam. Preliminary SAR results were obtained and discussed based on screening data.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Pharmacotherapy, National Pharmaceutical University, Kharkiv, Ukraine.
- Department of Pharmaceutical, Organic, and Bioorganic Chemistry, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.
- Department of Technology of Biologically Active Substances, Pharmacy and Biotechnology, Lviv Polytechnic National University, Ukraine.
- Department of Regulation of Cell Proliferation and Apoptosis, Institute of Cell Biology of National Academy of Sciences of Ukraine, Lviv, Ukraine.
- Department of Chemistry, Taras Shevchenko National University, Kyiv, Ukraine.
- Enamine Ltd., Kyiv, Ukraine.
Förderung
- Verkhovna Rada of Ukraine
Zitieren
APA
Davydov, E., Hoidyk, M., Shtrygol', S., Karkhut, A., Polovkovych, S., Klyuchivska, O., Karpenko, O., Lesyk, R., & Holota, S. (2024). Evaluation of thiopyrano[2,3‐ d ]thiazole derivatives as potential anticonvulsant agents. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400357
Vancouver
Davydov E, Hoidyk M, Shtrygol' S, Karkhut A, Polovkovych S, Klyuchivska O, et al. Evaluation of thiopyrano[2,3‐ d ]thiazole derivatives as potential anticonvulsant agents. Archiv der Pharmazie. 2024. doi:10.1002/ardp.202400357
BibTeX
@article{Davydov2024,
author = {Davydov, Eduard and Hoidyk, Mykhailo and Shtrygol', Sergiy and Karkhut, Andriy and Polovkovych, Svyatoslav and Klyuchivska, Olga and Karpenko, Olexandr and Lesyk, Roman and Holota, Serhii},
title = {Evaluation of thiopyrano[2,3‐ d ]thiazole derivatives as potential anticonvulsant agents},
journal = {Archiv der Pharmazie},
year = {2024},
doi = {10.1002/ardp.202400357}
}
EUVIMED